MLO-Y4 osteocytic cell clones express distinct gene expression patterns characteristic of different stages of osteocyte differentiation by Atkinson, Emily G. et al.
Actualizaciones en Osteología, VOL. 13 - N° 3 - 2017 207
Atkinson E.G., et al.: Gene expression and morphology of MLO-nGFP clonesActual. Osteol 2017; 13(3): 207-213
Internet: http://www.osteologia.org.ar
ARTÍCULOS ORIGINALES / Originals
*Correspondencia: Department of Anatomy and Cell Biology, Indiana University School of Medicine, 635 Barnhill Drive, 
MS-5035, Indianapolis, IN 46202-5120. 
E-mail: lplotkin@iupui.edu
MLO-Y4 OSTEOCYTIC CELL CLONES EXPRESS DISTINCT GENE 
EXPRESSION PATTERNS CHARACTERISTIC OF DIFFERENT 
STAGES OF OSTEOCYTE DIFFERENTIATION
Emily G. Atkinson,1 Alejandro Marcial,1 Zuleima Sánchez,1 Christian Porter, 1 Lilian I. Plotkin.1,2*
1 Department of Anatomy & Cell Biology, Indiana University School of Medicine,
2 Roudebush Veterans Administration Medical Center, Indianapolis, IN, USA.
Abstract
Osteocytes are the most abundant bone cell 
and are formed when osteoblasts become em-
bedded in the bone matrix. Through changes in 
gene expression and paracrine effects, osteo-
cytes regulate the number of osteoblasts, bone 
forming cells, and osteoclasts, bone resorbing 
cells, which are needed to maintain bone mass. 
MLO-Y4 is the better characterized osteocytic 
cell line; however, lacks expression of scleros-
tin, the product of the SOST gene, which is 
fundamental for osteocyte function and blocks 
bone formation. With the objective to isolate 
MLO-Y4 clones with different gene expres-
sion profiles, we performed cultures at very 
low density of MLO-Y4 cells stably transfected 
with nuclear green fluorescent protein (MLO-
nGFP). Cell morphology was visualized under 
a fluorescence microscope. Once the cells 
reached 80% confluency, RNA was extracted 
and quantitative real time PCR was performed. 
Clones exhibit different sizes and morphology, 
with some cells showing a spindle-like shape 
and others with abundant projections and a 
star-like shape. Gene expression also differed 
among clones. However, none of the clones 
examined expressed SOST. We conclude that 
the MLO-nGFP clones constitute a useful tool 
to study osteocyte differentiation and the role 
of osteocytes in the control of bone formation 
and resorption in vitro. 
Key words: osteocytic cells, gene expres-
sion, cell morphology. 
Resumen
CLONES DE LAS CÉLULAS OSTEOCÍTICAS 
MLO-Y4 TIENEN DIFERENTES 
PATRONES DE EXPRESIÓN GÉNICA 
CARACTERÍSTICOS DE DIFERENTES 
ESTADÍOS DE DIFERENCIACIÓN 
OSTEOCÍTICA
Los osteocitos son las células más abun-
dantes del hueso y se forman cuando los os-
teoblastos se encuentran rodeados de matriz 
ósea. A través de cambios en la expresión 
génica y efectos paracrinos, los osteocitos 
controlan el número de osteoblastos que for-
man el hueso, y osteoclastos que resorben 
el hueso, células necesarias para mantener 
la masa ósea. Las células MLO-Y4 son la 
línea celular osteocítica más investigada; sin 
embargo, no expresan esclerostina, el pro-
ducto del gen SOST que bloquea la formación 
ósea y es indispensable para la función de los 
osteocitos.  Con el objetivo de aislar clones de 
las células MLO-Y4 con diferentes perfiles de 
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expresión génica, realizamos cultivos a muy 
baja densidad de las células transfectadas en 
forma estable con proteína verde fluorescente 
nuclear (MLO-nGFP). La morfología celular fue 
evaluada utilizando un microscopio de fluo-
rescencia. Una vez que las células alcanzaron 
el 80% de confluencia, el ARN fue extraído y 
analizado por PCR cuantitativa en tiempo real. 
Las células de los diferentes clones tienen 
diferentes tamaños y morfología, algunas cé-
lulas son fusiformes y otras con proyecciones 
citoplasmáticas abundantes y en forma de es-
trella. La expresión de los genes también varió 
en los distintos clones. Sin embargo, ninguno 
de ellos expresó SOST. En conclusión, los 
clones de las células MLO-nGFP constituyen 
una herramienta útil para estudiar la diferen-
ciación de los osteocitos y el rol de estas cé-
lulas en el control de la formación y resorción 
ósea in vitro. 
Palabras clave: células osteocíticas, expre-
sión génica, morfología celular.
Introduction
Osteoblasts, the bone forming cells, and 
osteoclasts, the bone resorbing cells, are nee-
ded in order to maintain bone mass.1 If there is 
an increase in osteoblasts and a decrease in 
osteoclasts, bone mass will increase. The vice- 
versa is also true; if there is an increase in os-
teoclasts and a decrease in osteoblasts, bone 
mass will decrease. Coupled remodeling of 
osteoclasts and osteoblasts results in optimal 
bone turnover rate and bone mass mainte-
nance. These processes are controlled by the 
actions of osteocytes, the cells buried in the 
bone matrix.2 Until the late 1990s, osteocytes 
were poorly studied due to their localization 
within the bone. Further, isolation of osteo-
cytes from bones and their culture maintaining 
cell morphology and gene expression profile 
was difficult. However, the main reason why 
the functional role of osteocytes remained un-
derstudied was the lack of cell lines available 
to study these cells in vitro.3 
In 1997, Dr. Bonewald’s group reported the 
characterization of an immortalized osteocytic 
cell line, MLO-Y4.2 These cells were isolated 
from long bones of mice expressing a T-antigen 
transgene under the control of the osteocalcin 
promoter. Expression of the transgene renders 
the cells immortalized, allowing for the gene-
ration of a cell line. MLO-Y4 osteocytic cells 
produce high amounts of osteocalcin and low 
amounts of alkaline phosphatase, and have 
morphology consistent with osteocytes. Since 
their description, numerous laboratories throug-
hout the world have utilized MLO-Y4 cells as os-
teocytic models to understand the mechanism 
of action of hormones, pharmacotherapeutic 
agents, and mechanical signals, as well as to 
investigate the cross-talk between osteocytes 
and other organs/tissues such as muscle and 
brain.2 Because of this, MLO-Y4 cells are the 
better characterized osteocytic cell line.
However, further studies and the discovery 
of new osteocyte-specific molecules showed 
that MLO-Y4 cells lack expression of sclerostin, 
the product of the SOST gene, which is funda-
mental for osteocyte function and blocks bone 
formation.4 In this study, we aimed to investi-
gate whether clones within a pool of MLO-Y4 
cells have different gene expression patterns 
and might represent a better model for osteo-
cytes. Towards this end, we generated clones 
of MLO-Y4 osteocytic cells stably transfected 
with nuclear green fluorescent protein (MLO-
nGFP), which allow us to visualize the mor-
phology of the cells under a fluorescence mi-
croscope.5 Although we did not find any clone 
expressing SOST, our studies uncovered diffe-
rent populations of MLO-Y4 cells that could be 
used to study osteoblast-osteocyte transition 
and the mechanism by which osteocytes regu-
late osteoclastogenesis. 
Materials and Methods
Materials
SuperFect was obtained from Qiagen (San-
ta Clarita, CA). Trizol reagent was purchased 
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from Invitrogen (Massachusetts, MA). Primers/
probes qPCR sets were purchased from Roche 
Applied Science (Indianapolis, IN) or Applied 
Biosystems (Foster City, CA). All other reagents 
and tissue culture material were obtained from 
Sigma Chemical Co (St. Louis, MO).
Establishment of MLO-Y4 cells stable 
transduced with green fluorescent protein
MLO-Y4 osteocytic cells were origina-
lly obtained from Dr. Lynda Bonewald3 and 
maintained in our laboratory since 1998.5 
Cells were cultured on calf skin collagen 
type I-coated plates in αMEM media con-
taining 2.5% fetal bovine serum and 2.5% 
bovine calf serum, 100 U/ml penicillin, and 
100 mg/ml streptomycin. Cells were plated 
at 1 × 104 to 2 × 104 cells/cm2 and media was 
changed every 2-3 days. The generation of 
MLO-Y4 osteocytic cells was previously re-
ported.5 Briefly, a plasmid containing the 
retroviral nuclear GFP construct was tran-
siently transfected into the packaging cell 
line Phoenix Eco using SuperFect (Qiagen, 
Santa Clarita, CA).5 Supernatants containing 
retroviral particles were collected 24-48 h 
after transfection, and used to infect cell 
cultures. Subconfluent MLO-Y4 osteocytic 
cells were exposed to viral supernatants in 
the presence of 8 µg/ml polybrene for 8 h 
and then incubated in fresh culture medium 
for 16 h. Transduced cells were selected by 
culturing them in the presence of 400 µg/ml 
of G418 for three weeks. Cells are designa-
ted as MLO-nGFP (pool). 
Cells were cultured on 10 cm collagen-
coated plates5 at very low density in order to 
obtain single cell cultures. From those, cell 
colonies growing as separated clones were 
picked up using a tip and transferred to 24 
well plates and continue cultured. Semi-con-
fluent cultures were then trypsinized and cells 
were frozen until used. Cell were thawed and 
plated in replicas of 6 for gene expression 
analysis or in 10 cm plates for imaging, as 
detailed below.
Microscope imaging and morphological 
analysis
Cells were seeded at 4.4×104 cells/cm2 on 
collagen-coated plates, as published.5 Twenty 
four hours after seeding, medium was changed 
to remove dead cells and debris and cells were 
cultured for additional 48 hours. Cells were 
then fixed in 10% neutral buffer formalin for 8 
minutes, washed twice with PBS and stored at 
4°C in PBS containing thimerosal to avoid bac-
terial contamination. Fluorescent images were 
collected on an EVOS fluorescence microsco-
pe system (Life Technologies, Carlsbad, CA),6 
and cell morphology was evaluated in 10 inde-
pendent fields at 40X magnification. 
RNA extraction and quantitative RT-PCR 
(qPCR)
Total RNA was extracted from cells using 
Trizol reagent (Invitrogen), as previously repor-
ted.6,7 mRNA was converted to cDNA using 
a high capacity cDNA reverse transcription 
kit (Applied Biosystems, Foster City, CA). 
qPCR was performed using glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) as hou-
se-keeping gene, and the ∆Ct method. Primers 
and probes were designed using the Assay De-
sign Center (Roche Applied Science) or were 
commercially purchased (Applied Biosystems). 
Statistical Analysis
Statistical analysis was performed with 
SigmaPlot. One-way ANOVA on the ranks 
was the statistical method used and a Dunn’s 
post-hoc test was performed. p < 0.05 was 
considered significant. 
Results
MLO-nGFP clones exhibit distinct mor-
phological features. Microscopic examination 
of MLO-nGFP cells revealed unique morpho-
logic features of the clones. Indeed, whereas 
the pool of MLO-nGFP contained cells with 
various shapes and sizes, the clones exhibited 
more distinct morphologies, as evidenced in 
the images for 7 representative clones (Fig. 1).
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elongated (fusiform), and cells of clones 2, 
7, 26, 27, and 34 exhibited cytoplasmic pro-
jections and a star-shaped morphology. Re-
garding size, cells from clones 2 and 29 were 
overall smaller that cells in clones 24 and 34. 
This evidence suggests that we were able to 
isolate individual cell types that might exhibit 
a particular repertoire of genes. 
Gene expression pattern varies among 
MLO-nGFP clones. qPCR analysis revealed 
the MLO-nGFP pool expressed undetectable 
levels of most genes investigated, with excep-
tion of RANKL and the housekeeping gene 
GAPDH (Fig. 2). 
The reason for the lack of detection of most 
genes in the pool is not clear. However, we 
can rule out the possibility of lack of enough 
cDNA, since the Ct values for GAPDH were 
approximately 21, similar to the values for clo-
nes 26 (Ct=23) and 27 (Ct=21), for example. 
Nevertheless, the MLO-nGFP clones exhibit 
different levels of expression of osteocytic ge-
nes. Although none of the clones expressed 
detectable levels of SOST, we could detect 
mRNA expression for other osteocytic genes 
such as dentin matrix protein 1 (DMP1), E11 
(also known as podoplanin) and fibroblast 
growth factor-23 (FGF23). For example, clone 
Figure 1. Clones of MLO-nGFP cells show unique 
morphologies. Images of MLO-nGFP osteocytic 
cells (pool) and representative clones under fluores-
cence microscopy. Scale bars correspond to 25 µm. 
Figure 2. Distinct pattern of osteocytic/osteoblastic 
gene expression in MLO-nGFP clones. Expression 
of the indicated osteocytic and osteoblastic ge-
nes relative to GAPDH was measured by qPCR. * 
p<0.05 versus MLO-nGFP pool by one-way ANOVA. 
Clones that show no expression of the correspon-
ding gene are indicated in grey.
gene are indicated in grey
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34, which exhibits a star-like shape, has high 
expression of E11 and DMP1 (although the di-
fference for the later did not reach significan-
ce, likely due to the high variation of the values 
and the multiple comparisons), markers of 
early osteocyte differentiation, no expression 
of keratocan, a gene enriched in osteoblasts; 
and absence of FGF23 and Sost expression, 
suggesting they represent early osteocytes. 
On the other hand, clones 1 and 29, exhibits a 
spindle-like shape, and, whereas clone 1 has 
the highest expression of DMP1 among the 
clones analyzed and low but detectable levels 
of E11, FGF23, and keratocan, clone 29 lacks 
E11, DMP1, and FGF23 expression and has 
relative high levels of keratocan, suggesting 
they represent late and early osteoblasts, res-
pectively. 
The expression of the genes involved in 
osteoclastogenesis ligand for the receptor ac-
tivator of NFkB (RANKL) and osteoprotegerin 
(OPG) also varied among the clones (Fig. 3), 
with some exhibiting high (such as clone 34), 
and others low (such as clone 1) RANKL/OPG 
ratio. 
Discussion
Our understanding of the role of osteo-
cytes in skeletal biology and in the interaction 
of bone with other tissues and organs have 
exhibited a substantial increase in the last 20 
years.8-10 These advances were originated in 
the isolation and initial characterization of the 
first osteocytic cell line, MLO-Y4 by Lynda 
Bonewald’s group.3 Since then, other osteo-
cytic cell lines have been generated by Dr. 
Bonewald and other groups, including MLO-
A5 and OCY454,11-13 but MLO-Y4 cells conti-
nue to be the most utilized osteocytic cell line. 
However, the use of this cell line is limited by 
the fact that they do not express SOST/scle-
rostin, a gene expressed only by osteocytes 
in bone and that is fundamental for the role 
of osteocytes as regulators of bone homeos-
tasis. 
Osteocytes are derived from osteoblasts 
once the bone forming cells have finished 
their synthetic activity and become surroun-
ded by mineralized matrix.1 Osteocytes and 
osteoblasts share expression of several ge-
nes, albeit at different relative levels. The di-
fferential expression of genes in the 2 cell ty-
pes has been studied by the Kalajzik’s group, 
who performed gene array analysis to deter-
mine differentially expressed genes.14 This la-
ter study, as well as others have shown that, 
in addition to SOST/sclerostin, other genes 
are expressed in higher levels in osteocytes 
compared to osteoblasts.1 Of those, we cho-
se to measure the levels of E11, expressed in 
early embedding osteocytes and responsible 
for dendrite formation; DMP-1, expressed in 
early and mature osteocytes and involved in 
phosphate metabolism and mineralization; 
and FGF-23, also expressed in early and ma-
ture osteocytes and responsible for phospha-
te metabolism. All these genes are also ex-
pressed in late osteoblasts, although at lower 
levels than in osteocytes. We also measured 
the levels of keratocan, a gene that is expres-
sed at higher levels in osteoblasts compared 
to osteocytes and that has been used as a 
Figure 3. Osteoclastogenic cytokines are expres-
sed at different levels in MLO-nGFP clones. Ex-
pression of the indicated osteoclastogenic cyto-
kines relative to GAPDH was measured by qPCR. 
* p<0.05 versus MLO-Y4-nGFP pool by one-way 
ANOVA. Clones that show no expression of the co-
rresponding gene are indicated in grey.
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marker of osteoblastic cells.14 SOST/scleros-
tin, on the other hand, is expressed in late os-
teocytes, regulates osteoblast differentiation 
and bone formation, and has not been shown 
to be expressed in osteoblasts.1 
In addition to the regulation of bone forma-
tion and mineralization, osteocytes control the 
formation and survival of osteoclasts through 
the production of RANKL and OPG, cytokines 
that promote and inhibit osteoclastogenesis, 
respectively.8 Similar to the levels of osteo-
cytic genes, the expression of RANKL and 
OPG varied in the different clones. RANKL is 
a membrane bound protein that can also act 
as a soluble cytokine, activating RANK in os-
teoclast precursors leading to osteoclast di-
fferentiation.15 RANKL can also activate RANK 
in mature osteoclasts and promote osteoclast 
survival. OPG binds to RANKL and acts as a 
decoy receptor, blocking RANKL interaction 
with RANK and therefore, osteoclast differen-
tiation. It is important, therefore, to estimate 
the ratio between RANKL and OPG, which 
will dictate a pro- or anti-osteoclastogenic 
condition. We found that some clones, such 
as clone 6, express relatively low levels of 
RANKL and high levels of OPG, which should 
lead to low RANKL/OPG ratio and reduced 
osteoclastogenic potential compared to the 
MLO-nGFP pool. On the other hand, clone 
34 exhibits higher RANKL levels compared to 
OPG, which should favor osteoclastogene-
sis. Future co-culture studies using the MLO-
nGFP clones and osteoclast precursors will 
determine whether these changes in mRNA 
levels translate into different ability to induce 
osteoclast differentiation in vitro. 
Overall, cells expressing higher levels of 
osteocytic genes also express higher levels of 
RANKL and OPG. This is consistent with evi-
dence that osteocytes are one of the main sour-
ces of cytokines associated with osteoclast di-
fferentiation.16 Furthermore, the higher RANKL/
OPG ratio could be detected in clones exhibi-
ting higher number of projections, such as clo-
nes 2 and 34, again reinforcing the notion that 
osteocytes regulate osteoclastogenesis. 
In summary, we found that MLO-Y4 clones 
exhibit different sizes and morphology, with 
some cells showing a spindle-like shape and 
others with abundant projections and a star-
like shape. Clones of MLO-nGFP cells do not 
express SOST, and express different levels of 
other osteocytic genes. MLO-nGFP clones 
constitute a useful tool to study osteocyte diffe-
rentiation and the role of osteocytes in the con-
trol of bone formation and resorption in vitro.
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